Francesca Del Bufalo

21PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNeurology and neuromuscular diseasesAutonomic nervous systemHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 03, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia.

Marco Becilli, Pietro Merli, Mattia Algeri

|Feb 05, 2026
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.

Marco Becilli, Markus Metzler, Claudia Bracaglia

|Sep 09, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Franco Locatelli, Daria Pagliara, Maria A De Ioris

|Aug 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.

Franco Locatelli, Daria Pagliara, Maria A De Ioris

|Jun 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.

Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli

|Jan 15, 2025
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma.

Concetta Quintarelli, Francesca Del Bufalo, Maria Antonietta De Ioris

Pageof 4

Frequent Collaborators

11 joint publications

Franco Locatelli

8 joint publications

Biagio De Angelis

8 joint publications

Angela Mastronuzzi

7 joint publications

Concetta Quintarelli